Current role, techniques and outcomes of percutaneous biopsy of renal tumors

Expert Review of Anticancer Therapy

Volumn 9, Issue 6, 2009, Pages 773-783

  Volpe, Alessandro ^a   Jewett, Michael A S ^b  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diagnosis; Fine needle aspiration; Needle core biopsy; Renal cell carcinoma; Renal mass

Indexed keywords

ARTERIOVENOUS FISTULA; ASPIRATION BIOPSY; BLEEDING; BLEEDING TENDENCY; BODY BUILD; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; ECHOGRAPHY; FLUOROSCOPY; HUMAN; INFECTION; INTERNATIONAL NORMALIZED RATIO; KIDNEY CARCINOMA; KIDNEY TUMOR; MINIMALLY INVASIVE PROCEDURE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PERCUTANEOUS BIOPSY; PNEUMOTHORAX; PROTHROMBIN TIME; REVIEW; SAFETY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOPLASTIN TIME; TUMOR SEEDING; INSTRUMENTATION; LABORATORY DIAGNOSIS; METASTASIS; METHODOLOGY; NEEDLE; PATHOLOGY; STANDARD;

BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEEDLES; NEOPLASM METASTASIS; SPECIMEN HANDLING;

EID: 68849106880     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.48     Document Type: Review

References (89)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96 (2008).
2. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J. Natl Cancer Inst. 98, 1331-1334 (2006).
3. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28, 1165-1177 (1971).
4. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 281, 1628-1631 (1999).
5. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J. Urol. 170, 2217-2220 (2003).
6. Link RE, Bhayani SB, Allaf ME et al. Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J. Urol. 173, 1690-1694 (2005).
7. Gill IS, Matin SF, Desai MM et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J. Vrol. 170, 64-68 (2003).
8. Silverman SG, Coughlin BF, Seltzer SE, Swensson RG, Mueller PR. Current use of screening laboratory tests before abdominal interventions: a survey of 603 radiologists. Radiology 181, 669-673 (1991).
9. Charboneau JW, Reading CC, Welch TJ. CT and sonographically guided needle biopsy: current techniques and new innovations. Am. J. Roentgenol. 154, 1-10 (1990).
10. Herts BR. Imaging guided biopsies of renal masses. Curr. Opin. Urol. 10, 105-109 (2000).
11. Lebret T, Poulain JE, Molinie V et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J. Urol. 178, 1184-1188 (2007).
12. Volpe A, Mattar K, Finelli A et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J. Urol. 180, 2333-2337 (2008).
13. Rybicki FJ, Shu KM, Cibas ES, Fielding JR, van Sonnenberg E, Silverman SG. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. Am. J. Roentgenol. 180, 1281-1287 (2003).
14. Appelbaum AH, Kamba TT, Cohen AS, Qaisi WG, Amirkhan RH. Effectiveness and safety of image-directed biopsies: coaxial technique versus conventional fine-needle aspiration. South Med. J. 95. 212-217 (2002).
15. Sheafor DH, Paulson EK, Kliewer MA, DeLong DM, Nelson RC. Comparison of sonographic and CT guidance techniques: does CT fluoroscopy decrease procedure time? Am. J. Roentgenol. 174, 939-942 (2000).
16. Ljung BM, Geller DA. Fine-needle aspiration techniques for biopsy of deep-seated impalpable targets: a primer for radiologists. Am. J. Roentgenol. 171, 325-328 (1998).
17. Hopper KD, Abendroth CS, Sturtz KW, Matthews YL, Shirk SJ. Fine-needle aspiration biopsy for cytopathologic analysis: utility of syringe handles, automated guns, and the nonsuction method. Radiology 185, 819-824 (1992).
18. Renshaw AA, Cibas ES. Kidney and adrenal gland. In: Cytology: Diagnostic principles and Clinical Correlates (Second Edition). Cibas ES, Ducatman BS (Eds). Saunders, Edinburgh, Scotland 383-404 (2003).
19. Truong LD, Todd TD, Dhurandhar B, Ramzy I. Fine-needle aspiration of renal masses in adults: analysis of results and diagnostic problems in 108 cases. Diagn. Cytopathol. 20, 339-349 (1999).
20. Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J. Urol. 171, 1802-1805 (2004).
21. Wunderlich H, Hindermann W, Al Mustafa AM, Reichelt O, Junker K, Schubert J. The accuracy of 250 fine needle biopsies of renal tumors. J. Urol. 174, 44-46 (2005).
22. Vasudevan A, Davies RJ, Shannon BA, Cohen RJ. Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int. 97, 946-949 (2006).
23. Nagy A, Buzogany I, Kovacs G. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes. Histopathology 44, 542-546 (2004).
24. Mazal PR, Exner M, Haitel A et al. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Hum. Pathol. 36, 22-28 (2005).
25. Brunelli M, Eble JN, Zhang S, Martignoni G, Delahunt B, Cheng L. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod. Pathol. 18, 161-169 (2005).
26. Barocas DA, Mathew S, DelPizzo JJ et al. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU Int. 99, 290-295 (2007).
27. Barocas DA, Rohan SM, Kao J et al. Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis. J. Urol. 176, 1957-1962 (2006). òò This paper shows that the addition of a
28. Brierly RD, Thomas PJ, Harrison NW, Fletcher MS, Nawrocki JD, Ashton-Key M. Evaluation of fine-needle aspiration cytology for renal masses. BJU Int. 85, 14-18 (2000).
29. Wood BJ, Khan MA, McGovern F, Harisinghani M, Hahn PF, Mueller PR. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J. Urol. 161, 1470-1474 (1999).
30. Lechevallier E, Andre M, Barriol D et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 216, 506-510 (2000).
31. Maturen KE, Nghiem HV, Caoili EM, Higgins EG, Wolf JS Jr, Wood DP Jr. Renal mass core biopsy: accuracy and impact on clinical management. Am. J. Roentgenol. 188, 563-570 (2007).
32. Beland MD, Mayo-Smith WW, Dupuy DE, Cronan JJ, DeLellis RA. Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate? Am. J. Roentgenol. 188, 792-797 (2007).
33. Schmidbauer J, Remzi M, Memarsadeghi M et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur. Urol. 53(5), 1003-1011 (2007).
34. Somani BK, Nabi G, Thorpe P, N'Dow J, Swami S, McClinton S. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up. Eur. Urol. 51, 1289-1295 (2007).
35. Cardella JF, Bakal CW, Bertino RE et al. Quality improvement guidelines for image-guided percutaneous biopsy in adults. J. Vasc. Interv. Radiol. 14, S227-S230 (2003).
36. Welch TJ, Sheedy PF 2nd, Johnson CD, Johnson CM, Stephens DH. CT-guided biopsy: prospective analysis of 1,000 procedures. Radiology 171, 493-496 (1989).
37. Herts BR, Baker ME. The current role of percutaneous biopsy in the evaluation of renal masses. Semin. Urol. Oncol. 13, 254-261 (1995).
38. Gibbons RP, Bush WH Jr, Burnett LL. Needle tract seeding following aspiration of renal cell carcinoma. J. Urol. 118, 865-867 (1977).
39. Kiser GC, Totonchy M, Barry JM. Needle tract seeding after percutaneous renal adenocarcinoma aspiration. J. Urol. 136, 1292-1293 (1986).
40. Shenoy PD, Lakhkar BN, Ghosh MK, Patil UD. Cutaneous seeding of renal carcinoma by Chiba needle aspiration biopsy. Case report. Acta Radiol. 32, 50-52 (1991).
41. Wehle MJ, Grabstald H. Contraindications to needle aspiration of a solid renal mass: tumor dissemination by renal needle aspiration. J. Urol. 136, 446-448 (1986).
42. Auvert J, Abbou CC, Lavarenne V. Needle tract seeding following puncture of renal oncocytoma. Prog. Clin. Biol. Res. 100, 597-598 (1982).
43. Abe M, Saitoh M. Selective renal tumour biopsy under ultrasonic guidance. Br. J. Urol. 70, 7-11 (1992).
44. Caoili EM, Bude RO, Higgins EJ, Hoff DL, Nghiem HV. Evaluation of sonographically guided percutaneous core biopsy of renal masses. Am. J. Roentgenol. 179, 373-378 (2002).
45. Slywotzky C, Maya M. Needle tract seeding of transitional cell carcinoma following fine-needle aspiration of a renal mzss. Abdom. Imaging, 174-176 (1994).
46. Ralls PW, Barakos JA, Kaptein EM et al. Renal biopsy-related hemorrhage: frequency and comparison of CT and sonography. J. Comput. Assist. Tomogr. 11, 1031-1034 (1987).
47. Hopper KD, Yakes WF. The posterior intercostal approach for percutaneous renal procedures: risk of puncturing the lung, spleen, and liver as determined by CT. Am. J. Roentgenol. 154, 115-117 (1990).
48. Karampekios S, Hatjidakis AA, Drositis J, Gourtsoyiannis N. Artificial paravertebral widening for percutaneous CT-guided adrenal biopsy. J. Comput. Assist. Tomogr. 22, 308-310 (1998).
49. Hara I, Miyake H, Hara S, Arakawa S, Hanioka K, Kamidono S. Role of percutaneous image-guided biopsy in the evaluation of renal masses. Urol. Int. 67, 199-202 (2001).
50. Harisinghani MG, Maher MM, Gervais DA et al. Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery? Am. J. Roentgenol. 180, 755-758 (2003).
51. Eshed I, Elias S, Sidi AA. Diagnostic value of CT-guided biopsy of indeterminate renal masses. Clin. Radiol. 59, 262-267 (2004).
52. Shah RB, Bakshi N, Hafez KS, Wood DP Jr, Kunju LP. Image-guided biopsy in the evaluation of, renal mass lesions in contemporary urological practice: indications, adequacy, clinical impact, and limitations of the pathological diagnosis. Hum. Pathol. 36, 1309-1315 (2005).
53. Kummerlin I, ten Kate F, Smedts F et al. Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur. Urol. 53, 1219-1225 (2008).
54. Al Nazer M, Mourad WA. Successful grading of renal-cell carcinoma in fine-needle aspirates. Diagn. Cytopathol. 22, 223-226 (2000).
55. Cristallini EG, Paganelli C, Bolis GB. Role of fine-needle aspiration biopsy in the assessment of renal masses. Diagn. Cytopathol. 7, 32-35 (1991).
56. Niceforo J, Coughlin BF. Diagnosis of renal cell carcinoma: value of fine-needle aspiration cytology in patients with metastases or contraindications to nephrectomy. Am. J. Roentgenol. 161, 1303-1305 (1993).
57. Garcia-Solano J, Acosta-Ortega J, Perez-Guillermo M, Benedicto-Orovitg JM, Jimenez-Penick FJ. Solid renal masses in adults: image-guided fine-needle aspiration cytology and imaging techniques: 'two heads better than one?' Diagn. Cytopathol. 36, 8-12 (2008).
58. Campbell SC, Novick AC, Herts B et al. Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology 50, 25-29 (1997).
59. Cajulis RS, Katz RL, Dekmezian R, el-Naggar A, Ro JY. Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data. Acta Cytol. 37, 367-372 (1993).
60. Leiman G. Audit of fine needle aspiration cytology of 120 renal lesions. Cytopathology 1, 65-72 (1990).
61. Johnson PT, Nazarian LN, Feld RI et al. Sonographically guided renal mass biopsy: indications and efficacy. J. Ultrasound Med. 20, 749-753 (2001).
62. Khan AA, Shergill IS, Quereshi S, Arya M, Vandal MT, Gujral SS. Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists. BMC Urol. 7, 10 (2007).
63. Tuncali K, van Sonnenberg E, Shankar S, Mortele KJ, Cibas ES, Silverman SG. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. Am. J. Roentgenol. 183, 575-582 (2004).
64. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MAS. The natural history of incidentally detected small renal masses. Cancer 100, 738-745 (2004).
65. Kassouf W, Aprikian AG, Laplante M, Tanguay S. Natural history of renal masses followed expectantly. J. Urol. 171, 111-113 (2004).
66. Wehle MJ, Thiel DD, Petrou SP, Young PR, Frank I, Karsteadt N. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 64, 49-52 (2004).
67. Kato M, Suzuki T, Suzuki Y, Terasawa Y, Sasano H, Arai Y. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J. Urol. 172, 863-866 (2004).
68. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J. Urol. 175, 425-431 (2006).
69. Abou Youssif T, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 110, 1010-1014 (2007).
70. Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J. Urol. 180, 505-508 (2008).
71. Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy: a renaissance? J. Urol. 179, 20-27 (2008).
72. Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 112. 1051-1057 (2008).
73. Remzi M, Ozsoy M, Klingler HC et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J. Urol. 176, 896-899 (2006).
74. Herts BR, Baker ME. The current role of percutaneous biopsy in the evaluation of renal masses. Semin. Urol. Oncol. 13, 254-261 (1995).
75. Imaide Y, Saitoh M. [Clinical implication of selective renal tumor biopsy]. Hinyokika Kiyo 41, 745-752 (1995).
76. Dechet CB, Zincke H, Sebo TJ et al. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J. Urol. 169, 71-74 (2003).
77. Juul N, Torp-Pedersen S, Gronvall S, Holm HH, Koch F, Larsen S. Ultrasonically guided fine needle aspiration biopsy of renal masses. J. Urol. 133, 579-581 (1985).
78. Zardawi IM. Renal fine needle aspiration cytology. Acta Cytol. 43, 184-190 (1999).
79. Murphy WM, Zambroni BR, Emerson LD, Moinuddin S, Lee LH. Aspiration biopsy of the kidney. Simultaneous collection of cytologic and histologic specimens. Cancer 56, 200-205 (1985).
80. Orell SR, Langlois SL, Marshall VR. Fine needle aspiration cytology in the diagnosis of solid renal and adrenal masses. Scand. J. Urol. Nephrol. 19, 211-216 (1985).
81. Desai MM, Gill IS. Current status of cryoablation and radiofrequency ablation in the management of renal tumors. Curr. Opin. Urol. 12, 387-393 (2002).
82. Vasselli JR, Shih JH, Iyengar SR. Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc. Natl Acad. Sci. USA 100, 6958-6963 (2003).
83. Nenning H, Rassler J, Minh DH. Heterogeneity of DNA distribution pattern in renal tumours. Anal. Cell. Pathol. 14, 9-17 (1997).
84. Al-Aynati M, Chen V, Salama S, Shuhaibar H, Treleaven D, Vincic L. Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch. Pathol. Lab. Med. 127, 593-596 (2003).
85. Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R. Radical nephrectomy plus interferon-α-based immunotherapy compared with interferon α alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358, 966-970 (2001).
86. Flanigan RC, Salmon SE, Blumenstein BA et al. Nephrectomy followed by interferon α-2b compared with interferon α-2b alone for metastatic renal-cell cancer. N. Engl. J. Med. 345, 1655-1659 (2001).
87. Takahashi M, Rhodes DR, Furge KA et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl Acad. Sci. USA 98, 9754-9759 (2001).
88. Takahashi M, Yang XJ, Sugimura J et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 22, 6810-6818 (2003).
89. Young AN, Amin MB, Moreno CS et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol. 158, 1639-1651 (2001).